Drug class
Recombinant human insulin-like growth factor 1 (IGF-1); growth factor replacement biologic
Mechanism of action
Binds and activates the IGF-1 receptor, stimulating cellular growth, differentiation and metabolism. It provides replacement of deficient IGF-1 activity in severe primary IGF-1 deficiency.
General use cases
- Treatment of growth failure in paediatric patients aged 2 years and older with severe primary IGF-1 deficiency or growth hormone gene deletion with neutralising antibodies to growth hormone; not a substitute for growth hormone in other causes of short stature
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
